Octagon Capital Advisors LP Moon Lake Immunotherapeutics Transaction History

Octagon Capital Advisors LP

  • $307 Million
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$32.84 - $51.05 $4.86 Million - $7.56 Million
-148,000 Reduced 50.0%
148,000 $6.99 Million
Q1 2025

May 16, 2025
BUY
$36.75 - $54.34 $1.69 Million - $2.5 Million
46,000 Added 18.4%
296,000 $11.6 Million
Q1 2025

May 15, 2025
BUY
$36.75 - $54.34 $9.19 Million - $13.6 Million
250,000 New
250,000 $9.77 Million

Others Institutions Holding MLTX

# of Institutions
181
Shares Held
38.5M
Call Options Held
4.13M
Put Options Held
1.51M
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $472M
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email